Interestingly, two pancreatic NETs harbored a mutation in genes of the RAS-family, namely KRAS (with TP53 co-mutation) and HRAS (with AKT1 and DAXX co-mutation). This evidence concerns the gene HRAS and pancreatic neuroendocrine tumor.